TULIO EDUARDO FLESCH PFIFFER
Índice h a partir de 2011
9
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
10 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 10
conferenceObject Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment(2015) CHAU, I.; PARK, J. O.; RYOO, B. Y.; YEN, C. J.; POON, R.; PASTORELLI, D.; BLANC, J. F.; KUDO, M.; PFIFFER, T. F.; HATANO, E.; CHUNG, H. C.; KUBACKOVA, K.; PHELIP, J. M.; BRANDI, G.; OHKAWA, S.; LI, C. P.; OKUSAKA, T.; YANG, L.; ABADA, P.; ZHU, A.conferenceObject VAGINAL MORCELLATION INSIDE PROTECTIVE POUCH AND UTERINE EXTRATION IN CASES OF BULKY ENDOMETRIAL CANCERS: REPORT OF 30 CASES(2015) FAVERO, G.; MIGLINO, G.; KOEHLER, C.; PFIFFER, T.; SILVA, A.; RIBEIRO, A.; DOGAN, N. U.; ANTON, C.; BARACAT, E.; CARVALHO, J.conferenceObject LAPAROSCOPIC MODIFIED MCCALL CULDOPLASTY FOR THE CORRECTION OF UTEROVAGINAL PROLAPSE IN PATIENTS WITH CONCOMITANT GYNECOLOGIC TUMORS(2013) FAVERO, G.; HADDAD, J.; PFIFFER, T.; RIBEIRO, A.; ARAUJO, M. Pereira; MIGLINO, G.; MANCUSI, J.; BARACAT, E.; CARVALHO, J.conferenceObject Phase II trial of inetforrnin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas(2014) FERRARI, Anezlca Carvalho Rubin De Celia; PFIFFER, Tulio Eduardo Flesch; ALEX, Alexandra Khichfy; NEBULONL, Danielle R.; CARNELRO, Allyne Q.; CAPARELL, Fernanda Cunha; LEITE, Luiz Antonio Senna; BRAGHIROLI, Maria Ignez Freitas Meiro; LOBO, Juliana; HOFF, Paulo Marcelo; RIECHELMANN, Rachel PimentaconferenceObject High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment.(2015) REGO, Juliana Florinda De Mendonga; MEDEIROS, Raphael Salles S.; BRAGHIROLI, Maria Ignez Freitas Melro; GALVAO, Breno; BEZERRA NETO, Joao Evangelista; MUNHOZ, Rodrigo Ramella; GUERRA, Juliana Mariotti; KIMURA, Lidia; NONOGAKI, Suely; PFIFFER, Tulio Eduardo Flesch; CASTRO, Gilberto; HOFF, Paulo Marcelo; ROCHA FILHO, Duilio; COSTA, Frederico; RIECHELMANN, Rachel PimentaconferenceObject Pretreatment neutrophil to lymphocyte ratio and prognosis of patients with advanced hepatocelullar carcinoma treated with sorafenib.(2014) FONSECA, Leonardo Gomes; BARROSO-SOUSA, Romualdo; BLANCO, Bruna Paccola; VALENTE, Gabriel Luls; BRAGHLROLL, Maria Ignez Freltas Melro; PFIFFER, Tullo Eduardo Flesch; SABBAGA, Jorge; HOFF, Paulo MarceloconferenceObject Predictive Biomarkers of Response in Patients with Extrapulmonary Neuroendocrine Tumors (EPNET) Treated with Platin-Based Chemotherapy(2014) REGO, J. F.; MEDEIROS, R.; I, M. Braghiroli; BEZERRA NETO, J. E.; MUNHOZ, R.; PFIFFER, T.; GALVAO, B.; SIQUEIRA, S.; HOFF, P.; RIECHELMANN, R.- Low energy amplitude modulated radiofrequency electromagnetic fields in combination with standard treatment or as monotherapy to show improvement in quality of life in patients with advanced hepatocellular carcinoma.(2021) SOUSA, Micelange Carvalho; COSTA, Frederico; LIMA, Pablo Diego; SETOGUTE, Yone De Camargo; GUMZ, Brenda Pires; AZEVEDO, Fernanda; SABBAGA, Jorge; JARDIM, Denis Leonardo Fontes; FREITAS, Daniela; PFIFFER, Tulio Eduardo Flesch; SANTOS, Elizabeth; CASTRIA, Tiago Biachi De; HORVAT, Natally; FRANCA, Regis; TESTAGROSSA, Leonardo; IEMMA, Antonio Francisco; TUSZYNSKI, Jack
conferenceObject Evaluation of predictive biomarkers of response and prognosis in patients with high-grade extrapulmonary neuroendocrine carcinomas treated with platin-based chemotherapy.(2015) REGO, Juliana Florinda De Mendonga; MEDEIROS, Raphael Salles S.; BRAGHIROLI, Maria Ignez Freitas Melro; BEZERRA NETO, Joao Evangelista; MUNHOZ, Rodrigo Ramella; GUERRA, Juliana Mariotti; KIMURA, Lidia; NONOGAKI, Suely; PFIFFER, Tulio Eduardo Flesch; GALVAO, Breno; HOFF, Paulo Marcelo; ROCHA FILHO, Duilio; COSTA, Frederico; RIECHELMANN, Rachel PimentaconferenceObject Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of patients with elevated alpha-fetoprotein (AFP) from the randomized phase III REACH study(2015) ZHU, Andrew X.; RYOO, Baek-Yeol; YEN, Chia-Jui; KUDO, Masatoshi; POON, Ronnie Tung-Ping; PASTORELLI, Davide; BLANC, Jean-Frederic; CHUNG, Hyun Cheol; BARON, Ari David; PFIFFER, Tulio Eduardo Flesch; OKUSAKA, Takuji; KUBACKOVA, Katerina; TROJAN, Jorg; SASTRE, Javier; CHAU, Ian; CHANG, Shao-Chun; ABADA, Paolo; YANG, Ling; HSU, Yanzhi; PARK, Joon Oh